Literature DB >> 29102971

Delayed-onset heparin-induced skin necrosis: a rare complication of perioperative heparin therapy.

Weh Kiat Gan1.   

Abstract

An uncommon case of delayed-onset dalteparin-induced skin necrosis in an 83-year-old Caucasian female patient associated with heparin-induced thrombocytopaenia (HIT) presenting on day 30 following dalteparin therapy is reported. Investigations revealed mild thrombocytopaenia with normal protein C, protein S, coagulation screen and positive test for heparin-platelet factor-4 antibody. Clinical diagnosis of heparin-induced skin necrosis with HIT was made. Dalteparin injection was discontinued promptly and substituted with fondaparinux therapy. The patient achieved good recovery following cessation of dalteparin therapy and was subsequently discharged. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  Dermatology; Drug Therapy Related To Surgery; Skin; Unwanted Effects / Adverse Reactions

Mesh:

Substances:

Year:  2017        PMID: 29102971      PMCID: PMC5747761          DOI: 10.1136/bcr-2017-221388

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  10 in total

1.  Heparin-induced thrombocytopenia: overview and treatment.

Authors:  Daniel A Zinkovsky; Marilena S Antonopoulos
Journal:  P T       Date:  2008-11

2.  A fatal case of enoxaparin induced skin necrosis and thrombophilia.

Authors:  Yona Nadir; Yoav Mazor; Bergman Reuven; Galit Sarig; Benjamin Brenner; Norberto Krivoy
Journal:  Eur J Haematol       Date:  2006-08       Impact factor: 2.997

3.  Pharmacological and clinical differences between low-molecular-weight heparins: implications for prescribing practice and therapeutic interchange.

Authors:  Geno J Merli; James B Groce
Journal:  P T       Date:  2010-02

4.  Fondaparinux for the treatment of suspected heparin-induced thrombocytopenia: a propensity score-matched study.

Authors:  Matthew Kang; Majed Alahmadi; Sonja Sawh; Michael J Kovacs; Alejandro Lazo-Langner
Journal:  Blood       Date:  2014-12-16       Impact factor: 22.113

Review 5.  Low molecular weight heparin-induced skin necrosis-a systematic review.

Authors:  A E Handschin; O Trentz; H J Kock; G A Wanner
Journal:  Langenbecks Arch Surg       Date:  2004-11-27       Impact factor: 3.445

Review 6.  Heparin induced thrombocytopenia: diagnosis and management update.

Authors:  I Ahmed; A Majeed; R Powell
Journal:  Postgrad Med J       Date:  2007-09       Impact factor: 2.401

7.  Incidence and causes of heparin-induced skin lesions.

Authors:  Marc Schindewolf; Svantje Schwaner; Manfred Wolter; Hartmut Kroll; Andreas Recke; Roland Kaufmann; Wolf-Henning Boehncke; Edelgard Lindhoff-Last; Ralf J Ludwig
Journal:  CMAJ       Date:  2009-09-28       Impact factor: 8.262

8.  Enoxaparin-induced skin necrosis: a fatal outcome.

Authors:  Sarabjeet Singh; Meenakshi Verma; Amol Bahekar; Preeti Agrawal; Jasleen Duggal; Maria Iliescu; Pam Khosla; Shirin Muzaffar
Journal:  Am J Ther       Date:  2007 Jul-Aug       Impact factor: 2.688

9.  Hypersensitivity reactions to heparin: delayed onset thrombocytopenia and necrotizing skin lesions.

Authors:  C F Platell; E G Tan
Journal:  Aust N Z J Surg       Date:  1986-08

10.  Heparin induced thrombocytopenia: case presentation and review.

Authors:  Ronny A Cohen; Mariely Castellano; Christine A Garcia
Journal:  J Clin Med Res       Date:  2012-01-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.